| |
 |
Editorial [Hot Topic: Enzymes as Useful Tools and Potential Targets in Cancer Chemotherapy (Guest Editor: P. Ruzza and L. Quintieri)]
 |
| |
|
pp.716-716 (1) Authors: P. Ruzza, L. Quintieri |
| |
|
|
| |
|
Tyrosinase Activated Melanoma Prodrugs
|
| |
|
pp.717-727 (11) Authors: Samaila Jawaid, Tariq H. Khan, Helen M.I. Osborn, Nana Aba O. Williams |
| |
|
|
| |
|
Proteases as Anti-Cancer Targets - Molecular and Biological Basis for Development of Inhibitor-Like Drugs Against Cancer
|
| |
|
pp.728-762 (35) Authors: A. Bialas, P. Kafarski |
| |
|
|
| |
|
Glutathione Transferases as Targets for Cancer Therapy
|
| |
|
pp.763-777 (15) Authors: Paolo Ruzza, Antonio Rosato, Carlo Riccardo Rossi, Maura Floreani, Luigi Quintieri |
| |
|
|
| |
|
ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents
|
| |
|
pp.778-786 (9) Authors: Giorgio Cozza, Andrea Bortolato, Ernesto Menta, Ennio Cavalletti, Silvano Spinelli, Stefano Moro |
| |
|
|
| |
|
WT1 Peptide Vaccine as a Paradigm for “Cancer Antigen-Derived Peptide”-Based Immunotherapy for Malignancies: Successful Induction of Anti-Cancer Effect by Vaccination with a Single Kind of WT1 Peptide
|
| |
|
pp.787-797 (11) Authors: Yoshihiro Oka, Akihiro Tsuboi, Fumihiro Fujiki, Zheyu Li, Hiroko Nakajima, Naoki Hosen, Toshiaki Shirakata, Sumiyuki Nishida, Yusuke Oji, Ichiro Kawase, Haruo Sugiyama |
| |
|
|
| |
|
The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents
|
| |
|
pp.798-803 (6) Authors: Anna E. Maciag, Joseph E. Saavedra, Harinath Chakrapani |
| |
|
|
| |
|
Acronycine Derivatives: A Promising Series of Anti-Cancer Agents
|
| |
|
pp.804-815 (12) Authors: Q. C. Nguyen, T. T. Nguyen, R. Yougnia, T. Gaslonde, H. Dufat, S. Michel, F. Tillequin |
| |
|
|
| |
|
Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists
|
| |
|
pp.816-821 (6) Authors: Annika Bundscherer, Albrecht Reichle, Christian Hafner, Stefanie Meyer, Thomas Vogt |
| |
|
|
